<DOC>
	<DOCNO>NCT02126670</DOCNO>
	<brief_summary>The purpose study determine whether ACT01 effective tolerable alone use combination Comp01 , Comp02 , Comp03 Comp04 patient facial and/or scalp keratosis .</brief_summary>
	<brief_title>ACT01 Combination With Comp01-04 Patients With Actinic Keratosis</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>1 . Presence actinic keratosis lesion face and/or scalp within 25 cm2 contiguous area contain least four lesion nonhypertrophic nonhyperkeratotic large 6 mm long diameter . 2 . Age 3085 year , inclusive . 3 . Good general health determine investigator support medical history normal clinically significant abnormal vital sign ( blood pressure pulse ) . 1 . Severe , uncontrolled autoimmune , cardiovascular , gastrointestinal , hematological , hepatic , neurological , pancreatic , pulmonary renal disease . 2 . Dermatologic condition present face acne , atopic dermatitis , seborrheic dermatitis , eczema , rosacea , albinism . 3 . Application 1 ) chemical peel , 2 ) dermabrasion , 3 ) laser abrasion , 4 ) PUVA ( psoralen plus ultraviolet A ) therapy , 5 ) UVB therapy intend treatment area within 180 day prior Baseline Visit . 4 . Use sun lamp sun tan bed booths 14 day prior Baseline Visit .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>